| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 05/29/2008 | US20080125435 E. g., 1-(3-chloro-phenyl)-3-[1-(7-chloro-quinolin-4-yl)-piperidin-4-yl]-thiourea; regulation of ovulation, modulation of prostaglandin E2 receptors; fertilization, nidation, decidualization (e.g. placenta formation) and menstruation; hypermenorrhea, dysmenorrhea; endometriosis; anticarcinogenic agents |
| 05/29/2008 | US20080125433 Method of treating hair loss using thyromimetic compounds |
| 05/29/2008 | US20080125423 N-methyl-N-(1-methyl-1H-indol-3-ylmethyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide as an enzyme inhibitor for both Fab I and Fab K which are used in the biosynthesis of fatty acids; enoyl-acyl-carrier protein renamed Fab 1; bactericides; fungicides; Staphylococcus aureus; antibiotics |
| 05/29/2008 | US20080125422 Use of 5ht4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions |
| 05/29/2008 | US20080125418 Benzimidazole derivatives and their use as kdr kinase protein inhibitors |
| 05/29/2008 | US20080125416 Sigma Receptor Inhibitors |
| 05/29/2008 | US20080125412 Containing a diazacycloalkane ring, especially a 1,4-diazepane ring, e.g., N-p-((4-(alpha-phenylmethoxycarbonylmethyl)-1,4-diazepan-1-yl)phenyl)-o-biphenylcarboxamide, for the treatment of hyperlipidemia, obesity and type II diabetes. |
| 05/29/2008 | US20080125409 N-tert-butyl-5-(5-methanesulfonylamino-2-pyridyl)-1-(6-methoxy-3-pyridyl)-1H-1,2,4-triazole-3-carboxamide; prophylactic and/or therapeutic agent for ischemic diseases; platelet aggregation suppressant |
| 05/29/2008 | US20080125399 N-[3-(trifluoromethyl)pyridin-2-yl]-4-methyl-6-methyl-3-oxo-4-aza-5 alpha -androst-5-en-17 beta -acetamide; useful for the treatment of conditions caused by androgen deficiency such as osteoporosis, osteopenia, glucocorticoid-induced osteoporosis, periodontal disease, cancer cachexia, Alzheimer's disease |
| 05/29/2008 | US20080124751 Combinatorial rosamine library and uses thereof |
| 05/29/2008 | CA2706070A1 Therapeutic tetrahydroisoquinoline-based compositions for cancer therapy |
| 05/29/2008 | CA2677335A1 Indozalyl sulphonamide derivatives useful as glucocorticoid modulators |
| 05/29/2008 | CA2670143A1 Pyrimidines and their use as cxcr2 receptor antagonists |
| 05/29/2008 | CA2670031A1 Heterobicyclic metalloprotease inhibitors |
| 05/29/2008 | CA2669839A1 2-hydroxy-1,3-diaminopropane derivatives |
| 05/29/2008 | CA2669083A1 5, 6, or 7-substituted-3-(hetero)arylisoquinolinamine derivatives as antitumor agents |
| 05/29/2008 | CA2668661A1 Substituted pyrazole and triazole compounds as ksp inhibitors |
| 05/29/2008 | CA2668567A1 Pyrimidylmethyl-sulfonamide compounds useful as fungicides and against arthropods |
| 05/29/2008 | CA2668205A1 2-alkyl-indazole compounds for the treatment of certain cns-related disorders |
| 05/29/2008 | CA2650227A1 Substituted pyrazolopyrimidines |
| 05/28/2008 | EP1925614A1 Anxiolytic agents with reduced sedative and ataxic effects |
| 05/28/2008 | EP1924578A2 6-N-LINKED HETEROCYCLE-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-BENZO[d]AZEPINES AS 5-HT2C RECEPTOR AGONISTS |
| 05/28/2008 | EP1924577A1 Substituted benzimidazoles and methods of preparation |
| 05/28/2008 | EP1924576A1 The ocean wave energy converter (owec) |
| 05/28/2008 | EP1924575A1 Anthranilamides for controlling invertebrate pests |
| 05/28/2008 | EP1924574A2 Process for the syntesis of 5-(methyl-1h-imidazol-1-yl)-3-(tri fluorome th yl)-benzeneamine |
| 05/28/2008 | EP1924573A1 B-raf inhibitors |
| 05/28/2008 | EP1924568A1 Quinazoline derivatives useful in cancer treatment |
| 05/28/2008 | EP1924567A2 Process for the preparation of pyrimidinedione derivatives |
| 05/28/2008 | EP1924566A1 Diaminopyrimidines as p2x3 and p2x2/3 modulators |
| 05/28/2008 | EP1924565A1 Diaminopyrimidines as p2x3 and p3x2/3 modulators |
| 05/28/2008 | EP1924561A2 6-arylalkylamino- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 05/28/2008 | EP1924560A1 6-substituted- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 05/28/2008 | EP1924557A2 Carbazole derivatives |
| 05/28/2008 | EP1924551A2 Organic compounds |
| 05/28/2008 | EP1846381B1 HETEROARYLACETAMIDES AS FACTOR Xa INHIBITORS |
| 05/28/2008 | EP1701940B1 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri |
| 05/28/2008 | EP1660475B1 Pyrimidylpyrrole derivatives active as kinase inhibitors |
| 05/28/2008 | EP1485354B1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 05/28/2008 | EP1423379B1 Ortho-substituted aryl amides for controlling invertebrate pests |
| 05/28/2008 | EP1404668B1 Variolin derivatives and their use as antitumor agents |
| 05/28/2008 | EP1277471B1 Stable liquid preparation comprising sitafloxacin |
| 05/28/2008 | EP1218360B1 Triazine kinase inhibitors |
| 05/28/2008 | EP0766825B1 Preparation of derivatized 10,10'-substituted-9,9'-biacridine luminescent molecules and signal solutions |
| 05/28/2008 | CN101189243A Substituted heterocycles and their use as CHK1, PDK1 and PAK inhibitors |
| 05/28/2008 | CN101189241A Thienopyridine derivative, quinoline derivative, and quinazoline derivative having c-Met autophosphorylation inhibiting activity |
| 05/28/2008 | CN101189238A Piperazine-piperidines with CXCR3 antagonist activity |
| 05/28/2008 | CN101189228A Bicyclic [3.1.0] heteroaryl amides as type I glycine transport inhibitors |
| 05/28/2008 | CN101189226A Piperidin-4-yl-amide derivatives and their use as SST receptor subtype 5 antagonists |
| 05/28/2008 | CN101189225A Heteroaryl substituted pyrazinyl-piperazine-piperidines with CXCR3 antagonist activity |
| 05/28/2008 | CN101189224A Polymorphs of ethyl 3-[(2-{[4-(hexyloxycarbonylamino-iminomethyl)phenyl amino]-methyl}-1-methyl-1h-benzimidazole-5-carbonyl)pyridin-2-ylamino]propionate |
| 05/28/2008 | CN101189223A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 05/28/2008 | CN101189222A Tri-, tetra-substituted-3-aminopyrrolidine derivative |
| 05/28/2008 | CN101189214A Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-triazin-6-ones, and their use as fungicides |
| 05/28/2008 | CN101189208A 3-methanesulfonylquinolines as GABA-B enhancers |
| 05/28/2008 | CN101189012A Phenyl and pyridyl LTA4H modulators |
| 05/28/2008 | CN101186605A 2-vinyl-8-hydroxyquinoline derivative, preparation method and application thereof |
| 05/28/2008 | CN100390235C Azo compound and process of producing the same, amd novel compound and process of producing azo compounds using the same |
| 05/28/2008 | CN100390164C Isoquinoline compounds and medicinal use thereof |
| 05/28/2008 | CN100390163C 2-(2,6-dioxopiperidin-3-yl)-isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines |
| 05/28/2008 | CN100390156C Novel antibacterial compounds, process for their preparation and pharmaceutical compositions containing them |
| 05/28/2008 | CN100390149C Indazole derivatives |
| 05/27/2008 | US7378529 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/27/2008 | US7378526 Cholinergic ligands at the nicotinic acetylcholine receptors; diseases related to the cholinergic system; neurodegenerative disorders; pain; antiinflammatory; diagnostic or monitoring tools using labelled forms; 3-Phenyletynyl-quinuclidin-2-ene |
| 05/27/2008 | US7378525 CCR8 inhibitors |
| 05/27/2008 | US7378524 e.g., 6-chloro-2-methyl-4-(N-(2-(N-(p-methoxyphenylsulfonyl)-N-(2-(2,5-dimethoxy-4-nitroanilinocarbonyl)ethyl)amino)ethyl)amino)quinoline; used to treat inflammatory and immune diseases by binding to CXCR3 receptors. |
| 05/27/2008 | US7378522 Such as 6-(4-Acetamidophenoxy)-5-(N-benzyl-N-methylaminomethyl)-1-(2',6'-difluorobenzyl)-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid-ethyl ester; rapid effectiveness, bioavailability; low cost, simple synthesis |
| 05/27/2008 | US7378438 Asthma; side effect reduction; converting SH groups to SNO groups of N-benzylphthalimide usingHCl and NaNO2; epoxide or thioepoxid of N-benzylphthalimide; amination; 5-{2-[(1-Yloxyl-2,2,5,5-tetramethyl-pyrrolidin-3-ylmethyl)-amino]-1-S-nitroso-ethyl}-1,1,3,3-tetramethylisoindolin-2-yloxyl, hydrochloride |
| 05/27/2008 | US7378433 N-[4-(heteroarylmethyl)phenyl]-heteroarylamines |
| 05/27/2008 | US7378431 Amide derivatives as NMDA receptor antagonists |
| 05/27/2008 | US7378430 inhibitors of cGMP PDE, especially Type 5; erectile dysfunction and sexual disorders; 6-Bromo-N-[(3-chloro-methoxyphenyl)methyl]-2-(2-pyridinyl)-4-quinolinamine |
| 05/27/2008 | US7378422 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 05/27/2008 | US7378420 4-[(2,4-dichloro-phenyl)-phenyl-methyl]-piperazine-1-carboxylic acid benzhydryl-amide; conjugated to polyethylene glycol; analgesic, antidiabetic and anticarcinogenic agent, antidepressant, anxiolytic agent |
| 05/27/2008 | US7378413 2-amino-3-(alkyl)-pyrimidone derivatives |
| 05/27/2008 | US7378412 Pharmaceutical compounds |
| 05/27/2008 | US7378410 3,4,5-trihydroxy-2-methoxy-8,8-dimethyl-non-enoic acid ((3S,6S)-6-azido-2-oxo-azepan-3-yl)-amide; less toxicity, better selectivity in killing cancer cells, minimal effect on normal healthy cells |
| 05/27/2008 | US7378409 Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity |
| 05/27/2008 | US7378375 Substituted pyridine herbicides |
| 05/27/2008 | US7378240 hybridization probe; sequence-recognizing nucleic acid portion and a cyanine dye reporter portion; allows real time monitoring of PCR |
| 05/22/2008 | WO2008061236A2 Sulfoximines as kinase inhibitors |
| 05/22/2008 | WO2008061134A1 Derivatives of 18-amino substituted analogs of the geldamycin hydroquinon with cytotoxic activity for the treatment of cancer |
| 05/22/2008 | WO2008061016A1 N-substituted piperidinyl 4 -arylsulfonamides as modulators of the secreted frizzled related protein- 1 |
| 05/22/2008 | WO2008060998A1 Indole sulfonamides as sfrp-1 modulators |
| 05/22/2008 | WO2008060771A2 Pyrazole compounds |
| 05/22/2008 | WO2008060621A2 Aminopyrrolidines as chemokine receptor antagonists |
| 05/22/2008 | WO2008060269A2 Quinoline methanol compounds for the treatment and prevention of parasitic infections |
| 05/22/2008 | WO2008060190A2 Ligands of 5-ht6 receptors, a pharmaceutical composition, method for the production and use thereof |
| 05/22/2008 | WO2008059867A1 Novel 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | WO2008059866A1 Novel 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | WO2008059865A1 Novel 1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | WO2008059854A1 Piperidine derivatives or salts thereof |
| 05/22/2008 | WO2008059551A2 Process for the preparation of imatinib and intermediates thereof |
| 05/22/2008 | WO2008059370A2 Substituted bicyclocarboxyamide compounds |
| 05/22/2008 | WO2008059259A2 Anticancer compounds with a benzo ( 1, 2, 4 ) triazin-3yl-amine core |
| 05/22/2008 | WO2008059214A1 Bisamlde derivatives and use thereof as fatty acid synthase inhibitors |
| 05/22/2008 | WO2008059207A1 Cannabinoid receptor modulators |
| 05/22/2008 | WO2008059046A1 Macrocyclic inhibitors of hepatitis c virus |
| 05/22/2008 | WO2008059029A2 New polymorphs of ethyl 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazole-5-carbonyl)-pyridin-2-yl-amino]-propionate |
| 05/22/2008 | WO2008058967A1 Organic compounds |
| 05/22/2008 | WO2008058961A1 Heterocyclic derivatives as cetp inhibitors |